In the Review Article entitled “Stroke Prevention in Atrial Fibrillation: A Systematic Review” in the May 19, 2015, issue of JAMA,1 the ARISTOLE trial was incorrectly expanded. It should have read “Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation.” This article was corrected online.
Incorrect Study Name. JAMA. 2015;314(8):837. doi:10.1001/jama.2015.9181